Evidence map›Paper›PMID 34090528›Full record

ArticleAdvances in rheumatology (London, England)2021

Sacroiliitis in children and adolescents with familial Mediterranean fever.

Hülya Kaçmaz, Esin Aldemir, Ayşe Tanatar, Şerife Gül Karadağ, Mustafa Çakan, Hafize Emine Sönmez, Nuray Aktay Ayaz

Open access · diamondAbstract read
PubMed Publisher
In one paragraph

Article in Advances in rheumatology (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Hülya KaçmazDepartment of Pediatric Rheumatology, University of Health Sciences, Kanuni Sultan Süleyman Research and Training Hospital, Istanbul, Turkey.
Esin AldemirDepartment of Pediatric Rheumatology, University of Health Sciences, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.
Ayşe TanatarDepartment of Pediatric Rheumatology, Istanbul University Medical School, Istanbul, Turkey.
Şerife Gül KaradağDepartment of Pediatric Rheumatology, Sadi Konuk Research and Training Hospital, Istanbul, Turkey.
Mustafa ÇakanDepartment of Pediatric Rheumatology, University of Health Sciences, Zeynep Kamil Research and Training Hospital, Istanbul, Turkey.
Hafize Emine SönmezDepartment of Pediatric Rheumatology, Kocaeli University, Istanbul, Turkey.
Nuray Aktay AyazDepartment of Pediatric Rheumatology, Istanbul University Medical School, Istanbul, Turkey. nurayaktay@gmail.com.ORCID 0000-0003-3594-7387
Istanbul University · TRSağlık Bilimleri Üniversitesi · TRBakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi · TRKocaeli Üniversitesi · TRZeynep Kamil Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFamilial Mediterranean fever (FMF) is an autoinflammatory disease characterized by recurrent episodes of fever and serositis. Sacroiliitis can be observed in some FMF patients. This study aimed to compare the demographic, clinical, and laboratory findings, and treatment in children with FMF and sacroiliitis, and children with juvenile spondyloarthropathy (JSpA).

methodsIn total, 1687 pediatric FMF patients that were followed-up between May 2010 and June 2020 were evaluated retrospectively. Among them, those with sacroiliitis (n = 63) were included in the study and compared to patients with JSpA (n = 102).

resultsThe study included 63 FMF patients with sacroiliitis (38 males [60.3%] and 25 females [39.7%]) with a mean age of 15.2 ± 4.1 years. Mean age at symptom onset was 7.2 ± 5.05 years and mean age at diagnosis was 9.74 ± 4.67 years. The most common mutation in the FMF patients was M694V/M694V (n = 22). Patients were diagnosed with sacroiliitis with a mean of 12 months (range: 6-36 months) after the diagnosis of FMF. Among the FMF patients, 28 (44.4%) had enthesitis, 23 (36.5%) had heel pain, and 11 (17.4%) had low back pain. The study also included 102 JSpA patients (90 males [88.2%] and 12 females [11.8%]). Mean age of patients with JSpA was 16.1 ± 2.8 years. As compared to 102 JSpA patients, patients with FMF and sacroiliitis had higher acute phase reactants, whereas HLA-B27 positivity rate was lower. In addition, axial involvement rate was higher in the JSpA patients.

conclusionSacroiliitis is a common co-morbidity in FMF patients. The phenotypic features of these patients are different from patients with JSpA.

Indexed as

Familial Mediterranean FeverSacroiliitisAdolescentArthritis, JuvenileChildFemaleHumansMalePyrinRetrospective StudiesSpondylitis, AnkylosingYoung AdultPyrinChildhoodEnthesitis-related arthritisFamilial Mediterranean feverSacroiliitisSpondyloarthropathy

Identifiers

PMID34090528
OpenAlexW3170949066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.